Total Payments
$9,881
2024 Payments
$532.82
Companies
30
Transactions
436
Medicare Patients
916
Medicare Billing
$128,397
Payment Breakdown by Category
Food & Beverage$9,767 (98.8%)
Education$114.02 (1.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,767 | 418 | 98.8% |
| Education | $114.02 | 18 | 1.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,699 | 81 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,646 | 80 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $1,454 | 70 | $0 (2023) |
| Amarin Pharma Inc. | $656.14 | 29 | $0 (2023) |
| Lilly USA, LLC | $603.09 | 30 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $570.93 | 24 | $0 (2024) |
| Gilead Sciences, Inc. | $463.02 | 8 | $0 (2023) |
| GlaxoSmithKline, LLC. | $452.64 | 34 | $0 (2024) |
| PFIZER INC. | $361.37 | 12 | $0 (2023) |
| ABBVIE INC. | $354.65 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $532.82 | 16 | Novo Nordisk Inc ($160.11) |
| 2023 | $594.38 | 25 | Novo Nordisk Inc ($124.73) |
| 2022 | $837.25 | 35 | Novo Nordisk Inc ($194.01) |
| 2021 | $1,256 | 55 | AstraZeneca Pharmaceuticals LP ($283.19) |
| 2020 | $1,362 | 75 | AstraZeneca Pharmaceuticals LP ($349.46) |
| 2019 | $1,352 | 68 | SANOFI-AVENTIS U.S. LLC ($279.45) |
| 2018 | $1,736 | 67 | Novo Nordisk Inc ($283.28) |
| 2017 | $2,211 | 95 | AstraZeneca Pharmaceuticals LP ($414.10) |
All Payment Transactions
436 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: Respiratory | ||||||
| 09/05/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.11 | General |
| Category: Cardio-renal | ||||||
| 08/12/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $19.55 | General |
| Category: NEUROSCIENCE | ||||||
| 07/31/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $24.30 | General |
| Category: Respiratory | ||||||
| 07/11/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $26.63 | General |
| Category: Cardio-renal | ||||||
| 07/03/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $23.90 | General |
| Category: NEUROSCIENCE | ||||||
| 05/29/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $12.47 | General |
| Category: Diabetes | ||||||
| 05/10/2024 | Novo Nordisk Inc | Wegovy (Drug) | Education | In-kind items and services | $8.90 | General |
| Category: Obesity | ||||||
| 05/09/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $22.78 | General |
| Category: Cardio-renal | ||||||
| 04/04/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $125.00 | General |
| 04/03/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $23.40 | General |
| Category: RESPIRATORY | ||||||
| 03/27/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $21.14 | General |
| Category: Respiratory | ||||||
| 03/14/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $122.34 | General |
| Category: DIABETES | ||||||
| 03/14/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $22.83 | General |
| Category: NEUROSCIENCE | ||||||
| 03/06/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: Diabetes | ||||||
| 02/29/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $24.95 | General |
| Category: Cardio-renal | ||||||
| 11/02/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $23.60 | General |
| Category: Cardio-renal | ||||||
| 11/01/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.53 | General |
| Category: Diabetes | ||||||
| 10/25/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $19.56 | General |
| Category: NEUROSCIENCE | ||||||
| 09/27/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $24.69 | General |
| Category: Cardio-renal | ||||||
| 09/13/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $32.14 | General |
| Category: Diabetes | ||||||
| 09/06/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $21.98 | General |
| Category: Diabetes | ||||||
| 08/31/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $20.67 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/03/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $29.93 | General |
| Category: Cardio-renal | ||||||
| 07/19/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $27.98 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 165 | 349 | $59,972 | $23,793 |
| 2022 | 4 | 212 | 379 | $64,448 | $25,842 |
| 2021 | 4 | 263 | 507 | $87,089 | $42,204 |
| 2020 | 5 | 276 | 522 | $84,861 | $36,559 |
Total Patients
916
Total Services
1,757
Medicare Billing
$128,397
Procedure Codes
15
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 118 | 290 | $52,690 | $20,522 | 38.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 47 | 59 | $7,282 | $3,271 | 44.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 115 | 272 | $49,420 | $20,601 | 41.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 36 | 46 | $5,677 | $3,026 | 53.3% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 48 | 48 | $7,200 | $1,590 | 22.1% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 13 | 13 | $2,151 | $625.54 | 29.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 137 | 344 | $62,501 | $30,614 | 49.0% |
| 99497 | Advance care planning by the physician or other qualified health care professional, first 30 minutes | Office | 2021 | 71 | 86 | $12,900 | $4,797 | 37.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 44 | 63 | $7,775 | $4,306 | 55.4% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Office | 2021 | 11 | 14 | $3,912 | $2,487 | 63.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 131 | 326 | $59,231 | $24,478 | 41.3% |
| 99497 | Advance care planning by the physician or other qualified health care professional | Office | 2020 | 56 | 82 | $10,920 | $5,638 | 51.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 54 | 77 | $9,503 | $3,629 | 38.2% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Office | 2020 | 14 | 16 | $4,471 | $2,396 | 53.6% |
| G0444 | Annual depression screening, 15 minutes | Office | 2020 | 21 | 21 | $735.00 | $417.58 | 56.8% |
About Dr. Michael Dimitrion, MD
Dr. Michael Dimitrion, MD is a Internal Medicine healthcare provider based in Aiea, Hawaii. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1508878836.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Dimitrion, MD has received a total of $9,881 in payments from pharmaceutical and medical device companies, with $532.82 received in 2024. These payments were reported across 436 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($9,767).
As a Medicare-enrolled provider, Dimitrion has provided services to 916 Medicare beneficiaries, totaling 1,757 services with total Medicare billing of $128,397. Data is available for 4 years (2020–2023), covering 15 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Aiea, HI
- Active Since 08/13/2006
- Last Updated 06/23/2011
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1508878836
Products in Payments
- FARXIGA (Drug) $726.08
- SOLIQUA 100/33 (Biological) $676.93
- Vascepa (Drug) $656.14
- Ozempic (Drug) $624.50
- JARDIANCE (Drug) $474.84
- TOUJEO (Drug) $384.06
- SYMBICORT (Drug) $287.38
- Ranexa (Drug) $249.42
- BEVESPI AEROSPHERE (Drug) $228.71
- Tresiba (Drug) $226.84
- KRYSTEXXA (Biological) $220.60
- BYDUREON (Drug) $219.71
- QULIPTA (Drug) $218.54
- Victoza (Drug) $206.07
- Kerendia (Drug) $203.96
- TRULICITY (Drug) $200.13
- TRELEGY ELLIPTA (Drug) $191.13
- Rybelsus (Drug) $173.82
- SOLIQUA 100/33 (Drug) $155.67
- Axium INS DRG IPG (Device) $147.92
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Aiea
Roy Ebisu, Md, MD
Internal Medicine — Payments: $18,765
Internal Medicine $18,765
Stephen Miyasato, Md, MD
Internal Medicine — Payments: $18,084
Internal Medicine $18,084
Dr. Francis Buto, M.d, M.D
Internal Medicine — Payments: $14,868
Internal Medicine $14,868
Dr. Alan Oki, Md, MD
Internal Medicine — Payments: $14,573
Internal Medicine $14,573
Mark Nishihara, M.d, M.D
Internal Medicine — Payments: $14,206
Internal Medicine $14,206
Dr. Malissa Iida-Takashima, Md, MD
Internal Medicine — Payments: $13,761
Internal Medicine $13,761